These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 16239386

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?
    Murphy G, Nagase H.
    Nat Clin Pract Rheumatol; 2008 Mar; 4(3):128-35. PubMed ID: 18253109
    [Abstract] [Full Text] [Related]

  • 3. [Destruction of articular cartilage].
    Koike T.
    Clin Calcium; 2006 Sep; 16(9):1543-47. PubMed ID: 16951481
    [Abstract] [Full Text] [Related]

  • 4. [Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis].
    Fiedorczyk M, Klimiuk PA, Sierakowski S, Kita K.
    Pol Merkur Lekarski; 2006 Feb; 20(116):228-31. PubMed ID: 16708647
    [Abstract] [Full Text] [Related]

  • 5. Understanding the role of tissue degrading enzymes and their inhibitors in development and disease.
    Cawston TE, Wilson AJ.
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):983-1002. PubMed ID: 16980219
    [Abstract] [Full Text] [Related]

  • 6. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
    Milner JM, Rowan AD, Cawston TE, Young DA.
    Arthritis Res Ther; 2006 Oct; 8(5):R142. PubMed ID: 16919164
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Metalloproteinases: their role in arthritis and potential as therapeutic targets.
    Clark IM, Parker AE.
    Expert Opin Ther Targets; 2003 Feb; 7(1):19-34. PubMed ID: 12556200
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Molecular targets in osteoarthritis: metalloproteinases and their inhibitors.
    Burrage PS, Brinckerhoff CE.
    Curr Drug Targets; 2007 Feb; 8(2):293-303. PubMed ID: 17305507
    [Abstract] [Full Text] [Related]

  • 18. Effect of recombinant human tissue inhibitor of matrix metalloproteinase-1 in rabbit mandibular distraction osteogenesis: a histological and immunohistochemical study.
    Zheng LW, Ma L, Rabie AB, Cheung LK.
    J Craniomaxillofac Surg; 2006 Jul; 34(5):277-82. PubMed ID: 16777428
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multiphasic roles for matrix metalloproteinases after stroke.
    Rosell A, Lo EH.
    Curr Opin Pharmacol; 2008 Feb; 8(1):82-9. PubMed ID: 18226583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.